Not evaluated in the context of TBI-elicited behavioral changes, though antagonism of the receptor may be prophylactic in the treatment of migraines, whereas other 5-HT2 receptor family antagonists like ketanserin do not exert an anti-headache effect [98]. This evidence concerns the gene HTR2A and migraine disorder.